Also listed on JMD Pharma Creativity, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jun 9, 2042 · Medium confidence
20-year base term ends Jun 9, 2042
Why Medium: A parent in the chain could not be resolved.
Held by Atai Therapeutics, Inc.
Filed Aug 16, 2022 as application 17/889,013 · Granted May 9, 2023
Base term, 20 years from filing
Today
2022
2042
Clock starts
Jun 9, 2022
Jun 9, 2022
Term ends
Jun 9, 2042
Jun 9, 2042
Granted
May 9, 2023
May 9, 2023
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 9, 2022, when application 17/836,984, the earliest non-provisional in its chain, was filed (this one was filed Aug 16, 2022); a parent in its chain could not be resolved (the next row) | Jun 9, 2042 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 9, 2042 | Medium confidence |
This family
| Application 17/836,984 | Abandoned not computed | not computed |
| US 11,643,391 | this patent Jun 2042 | Jun 2042 |
| US 12,065,405 | In force Jun 2042 | Jun 2042 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 28, 2022 Reel 61891, frame 665 | Short, Glenn; Rao, Srinivas G.; Khan, Tanweer A. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Nov 28, 2022 Reel 61892, frame 104 | Perni, Robert B. | JMD Pharma Creativity, LLC | Assignment of Assignor's Interest |
| May 26, 2023 Reel 63778, frame 289 | JMD Pharma Creativity, LLC | Atai Life Sciences US, Inc. | Assignment of Assignor's Interest |
| Jul 6, 2023 Reel 64175, frame 571 | Atai Life Sciences US, Inc. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Oct 25, 2023 Reel 65345, frame 430 | Atai Life Sciences AG | Viridia Life Sciences, Inc. | Assignment of Assignor's Interest |
| Nov 1, 2023 Reel 65416, frame 595 | Viridia Life Sciences, Inc. | Atai Therapeutics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jun 2042
Term ends Jun 9, 2042. Maintenance fees still fall due before then
Citations
10
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.